Alessia Muzi | Immunology | Women Researcher Award

Published on by Molecular Biologist

Dr. Alessia Muzi | Immunology | Women Researcher Award

Principal investigator | Takis srl | Italy

Dr. Alessia Muzi is an accomplished Italian scientist and Principal Investigator at Takis Srl, leading pioneering research in oncology, monoclonal antibody engineering, and translational biotechnology. With over 20 years of experience, she has contributed significantly to therapeutic antibody development, vaccine innovation, and cancer immunotherapy. She holds a Ph.D. in Neurosciences from the University of Sacred Heart “Agostino Gemelli” and advanced degrees in Medical Biotechnology and Regulatory Medicine from the Universities of Rome “Tor Vergata” and “Sapienza.” As Head of the Monoclonal Antibody Laboratory at Takis, Dr. Muzi oversees cutting-edge projects focused on recombinant protein design and tumor-targeting antibodies. Her research bridges molecular biology and clinical applications, aiming to enhance the efficacy of cancer treatments and immunotherapies. Recipient of the FISA-2022-00899 Award for bispecific antibody development, she has co-authored 33 publications with an h-index of 20 and 1,121 citations across 1,018 documents. Dr. Muzi’s scientific leadership, regulatory expertise, and commitment to translational medicine have established her as a leading figure in Italian biomedical innovation and a driving force in advancing therapeutic strategies for oncology and infectious diseases.

Profile: Scopus | ORCID

Featured Publications

Novel Humanized Anti-HER3 Antibodies: Structural Characterization and Therapeutic Activity. (2025). Antibodies. Cited by 12.

Isolation and Characterization of Neutralizing Monoclonal Antibodies Against SARS-CoV-2 Spike Protein. (2024). Antibodies. Cited by 25.

A Linear DNA Vaccine Candidate Encoding SARS-CoV-2 RBD in Domestic Cats. (2023). Mol Ther Methods Clin Dev. Cited by 9.

A First-in-Human Trial of COVID-eVax DNA Vaccine. (2022). Mol Ther. Cited by 40.

Persistent B Cell Memory After SARS-CoV-2 Vaccination. (2022). Cell Host Microbe. Cited by 58.

COVID-eVax: Electroporated DNA Vaccine Candidate Encoding SARS-CoV-2 RBD. (2022). Mol Ther. Cited by 65.

The Nuts and Bolts of SARS-CoV-2 Spike RBD Heterologous Expression. (2021). Biomolecules. Cited by 33.

FABIANA FOSCA FERRARA | Immunology | Best Industrial Research Award

Published on by Molecular Biologist

Dr. Fabiana Fosca | Immunology | Best Industrial Research Award 

Senior Researcher | Takis srl | Italy

Dr. Fabiana Fosca Ferrara has earned distinguished recognition for her outstanding contributions to molecular biology and translational research. She was honored with the Best Ph.D. Thesis of the Year in Italy by FISV – Federazione Italiana Scienze della Vita, acknowledging her pioneering work in morphogenetic and cytological sciences. At Takis Srl, she has been an integral member of award-winning research teams advancing vaccine and antibody innovation in preclinical oncology and immunotherapy. Her FELASA European certifications and continuous professional training demonstrate her strong commitment to scientific integrity, regulatory compliance, and humane research practices. Dr. Ferrara has also played a key role in several European-funded projects and intellectual property developments that promote biomedical advancement. With 2,154 citations from 1,898 documents, 19 publications, and an h-index of 14, she exemplifies a career defined by research excellence, ethical leadership, and sustained impact in biotechnology and life sciences.

Profile: Scopus| ORCID

Featured Publications

Ferrara, F. F., et al. “Novel humanized anti-HER3 antibodies: Structural characterization and therapeutic activity.” Antibodies. – Cited by 12.

Ferrara, F. F., et al. “Isolation and characterization of neutralizing monoclonal antibodies against SARS-CoV-2 spike protein.” Antibodies. – Cited by 25.

Ferrara, F. F., et al. “COVID-eVax, an electroporated DNA vaccine candidate encoding SARS-CoV-2 RBD.” Molecular Therapy. – Cited by 180.

Ferrara, F. F., et al. “Novel benzazole derivatives endowed with potent antiheparanase activity.” Journal of Medicinal Chemistry. – Cited by 92.

Ferrara, F. F., et al. “Histone deacetylase-targeted treatment restores retinoic acid signaling in AML.” Cancer Research. – Cited by 550.

 

Junil Yoo | Biotechnology | Best Researcher Award

Published on by Molecular Biologist

Prof. Junil Yoo | Biotechnology | Best Researcher Award 

Prof. Junil Yoo | Inha university | South Korea

Prof. Jun-Il Yoo is an accomplished orthopedic surgeon and academic leader serving as Associate Professor at Inha University Hospital. His expertise encompasses geriatric orthopedics, sarcopenia, and bone health, with a strong focus on integrating artificial intelligence into musculoskeletal diagnostics and care. He has made significant contributions to orthopedic biomechanics and AI-based imaging, enhancing diagnostic precision and rehabilitation outcomes. Dr. Yoo’s education includes medical and doctoral degrees from Chung-Ang University and Chung-Buk National University, where he specialized in musculoskeletal medicine and clinical biomechanics. His professional experience spans leading roles at Gyeongsang National University Hospital, Seoul National University Bundang Hospital, and Chung-Buk National University Hospital, combining surgical excellence with academic mentorship. His research explores AI-driven body composition analysis, automated muscle segmentation, and predictive modeling for mobility in aging populations. Dr. Yoo’s numerous honors, including awards from national orthopedic and sarcopenia societies, reflect his innovative contributions to precision orthopedics and his commitment to improving patient care through advanced research and technology integration.

Profile: Google Scholar

Featured Publications

Kim, S. J., et al. Aging Clinical and Experimental Research. “Cross-sectional study comparing smart insoles and manual methods for short physical performance battery in hip fracture patients.” Cited by 12 articles.

Cha, Y. H., et al. Clinics in Orthopedic Surgery. “Comparing Stability, Gait, and Functional Score after Dual-Mobility Hip Arthroplasty.” Cited by 8 articles.

Kim, H. S., et al. PLOS One. “Correlation between thigh muscle volume and grip strength with automated segmentation.” Cited by 15 articles.

Ahn, S. H., et al. Scientific Reports. “Clinical outcomes of COVID-19 infection in patients with osteoporosis.” Cited by 22 articles.

Lee, S. Y., & Yoo, J. I. Journal of Ethnic Foods. “Soybean isoflavones potentially prevent sarcopenia: a systematic review.” Cited by 10 articles.

 

Seyithan TAYSI | Molecular Biology | Best Researcher Award

Published on by Molecular Biologist

Prof. Dr. Seyithan TAYSI | Molecular Biology | Best Researcher Award 

Professor | Gaziantep University | Turkey

Prof. Dr. Seyithan Taysi is a distinguished Professor of Medical Biochemistry at Gaziantep University, widely recognized for his pioneering work on oxidative stress, antioxidant mechanisms, free radicals, and molecular oncology. He earned his Ph.D. in Medical Biochemistry from Atatürk University, where his research on oxidative mechanisms and cellular stress regulation received the Jury’s Special Award for Best Article. Currently, he leads advanced biochemical research and teaching programs, having completed over ninety-five funded projects and holding six patents. His editorial service includes roles on international journal boards such as BioMed Research International and the International Journal of Clinical and Experimental Ophthalmology, where he has reviewed more than four hundred manuscripts. Prof. Taysi’s research focuses on oxidative and nitrosative stress, the Nrf2/Keap1 pathway, and antioxidant-based therapies, integrating biochemical and molecular approaches to improve cancer treatment and radioprotection. He has 162 documents cited by 3,969 documents, with 5,099 citations and an h-index of 39, reflecting his global influence and impact in biomedical research.

Profile: Scopus | ORCID | Google Scholar

Featured Publications

Taysi, S., et al. Oxidative stress modulation in cancer therapy. Free Radical Biology & Medicine. Cited by 45 articles.

Taysi, S., et al. Phytotherapeutic agents against radiation-induced cellular damage. Antioxidants (Basel). Cited by 38 articles.

Taysi, S., et al. Nrf2/Keap1 pathway as a therapeutic target in oxidative diseases. Frontiers in Molecular Biosciences. Cited by 62 articles.

Taysi, S., et al. Role of antioxidants in radiotherapy protection. BioMed Research International. Cited by 55 articles.

Taysi, S., et al. Oxidative stress biomarkers in cancer patients. Clinical Biochemistry. Cited by 97 articles.

Anastasia Stergioula | Cancer Biology | Best Researcher Award

Published on by Molecular Biologist

Dr. Anastasia Stergioula | Cancer Biology | Best Researcher Award 

Radiation Oncologist | National and Kapodistrian University of Athens | Greece

Dr. Anastasia Stergioula is a distinguished Radiation Oncologist with extensive clinical and research experience in advanced oncological treatments. She has been instrumental in implementing precision radiotherapy techniques, including IMRT, VMAT, SRS, SBRT, and brachytherapy, bridging medical innovation and patient care. Her research focuses on hypofractionated radiotherapy, re-irradiation strategies, and pathological responses in sarcoma patients, contributing to the development of safer and more effective treatments. Dr. Stergioula earned her medical degree and specialized training in radiation oncology, complemented by advanced studies in nanomedicine and translational oncology. She has served in leading hospitals and private centers, managing complex cases and participating in international clinical trials. Her academic contributions include multiple peer-reviewed publications and presentations at major international conferences. Her work has been recognized for advancing personalized oncological care, particularly in sarcomas, lung cancers, and rare tumors. With citations from 39 documents, 10 published articles, and an h-index of 4, Dr. Stergioula demonstrates a blend of clinical excellence, research impact, and commitment to innovation, making her a strong candidate for awards recognizing outstanding contributions in radiation oncology.

Profile: Scopus | ORCID

Featured Publications

Moutsatsos, A., Cotrutz, C., Stergioula, A., Tuleasca, C., & Pantelis, E. (n.d.). Time-resolved biological effective dose distributions in stereotactic radiosurgery for vestibular schwannomas. Physics in Medicine & Biology.

Laura Estrada | Molecular Biology | Best Researcher Award

Published on by Molecular Biologist

Prof. Laura Estrada | Molecular Biology | Best Researcher Award 

Researcher | Physics department University of Buenos Aires | Argentina

Prof. Laura Cecilia Estrada is a physicist, educator, and researcher whose work bridges advanced optical microscopy, nanotechnology, and interdisciplinary biophysics. She serves as Adjunct Professor at the Department of Physics, University of Buenos Aires and Independent Researcher at CONICET, where she leads pioneering investigations in fluorescence spectroscopy, nanoimaging, and virus-host interactions. Estrada completed her academic training in physics at the University of Buenos Aires, earning her Licenciatura and Ph.D. with highest distinction, and later expanded her expertise as a postdoctoral researcher and group leader at the University of California, Irvine. Her research focuses on fluorescence-based techniques, single-particle tracking, and nano-optics applied to both fundamental physics and biomedical sciences, with special emphasis on dengue and Zika virus proteins. Alongside her scientific contributions, she has played key leadership roles in professional societies and gender equity initiatives. Her work has been recognized nationally and internationally, including awards from the International Commission for Optics, the Biophysical Society, and Argentina’s INNOVAR program. She has supervised numerous theses, mentored young scientists, and fostered international collaborations. With 35 publications, 325 citations, and an h-index of 9, Estrada exemplifies scientific rigor, innovation, and social commitment in advancing both knowledge and equity.

Profile: Scopus

Featured Publications

Sallaberry, I., & Estrada, L. Unraveling viral protein-host membrane interaction for dengue and Zika. Biophysical Journal.

Leon, A., Sallaberry, I., Estrada, L., & Scorticati, C. Non-synonymous SNPs within GPM6A impair hippocampal neuron development. Biochimica et Biophysica Acta, 1872(3). Cited by 2.

Salzman, V., & Estrada, L. Replicative lifespan determination of yeast using microfluidic chip. Biology Open, 13(11). Cited by 5.

Gaggioli, E., Estrada, L., & Bruno, O. Boundary layer structures in transport theory. Physical Review E, 110. Cited by 3.

Philipp, N., Gratton, E., & Estrada, L. Protein-membrane interaction via radial FCS. Methods and Applications in Fluorescence, 11(4). Cited by 12.

Gabriel, M., & Estrada, L. Dengue Virus Capsid Protein Dynamics in live cells. Scientific Reports, 10. Cited by 45.

María Victoria Zelaya Huerta | Molecular Pathology | Women Researcher Award

Published on by Molecular Biologist

Dr. Maria Victoria Zelaya Huerta | Molecular Pathology | Women Researcher Award 

Dr. María Victoria Zelaya Huerta | University Hospital of Navarra | Spain

Dr. María Victoria Zelaya Huerta has established herself as a highly respected figure in pathology and neuropathology, with her work widely cited and recognized internationally. These metrics demonstrate the significance and influence of her contributions, underscoring how her studies have informed subsequent investigations and advanced medical knowledge. Beyond bibliometric achievements, she has been consistently acknowledged for her academic excellence and dedication to both clinical and translational research. Her recognition includes institutional distinctions for her pioneering work in breast cancer sentinel lymph node studies and molecular insights into Alzheimer’s disease. Dr. Zelaya has also been invited to present at numerous national and international pathology congresses, further highlighting the value of her research within the scientific community. Her international training and collaborations in Argentina, Spain, Taiwan, the Netherlands, and the United States have earned her fellowships and professional commendations, strengthening her global profile. With 47 scientific documents, over 992 total citations from 816 articles, and an h-index of 19, her research has had a strong impact across the fields of neuropathology, neurodegenerative diseases, and cancer pathology. As a tutor of residents, she continues to inspire and mentor the next generation of pathologists, solidifying her legacy as both a researcher and educator.

Profile: Scopus | ORCID

Featured Publications

Gelpi, E., Höftberger, R., Graus, F., & Duyckaerts, C. Neuropathological spectrum of anti-IgLON5 disease and stages of brainstem tau pathology: Updated neuropathological research criteria of the disease-related tauopathy. Acta Neuropathologica.

Profiling TREM2 expression in amyotrophic lateral sclerosis. Acta Neuropathologica.

Clinical, histopathologic and genetic features of rhabdoid meningiomas. International Journal of Molecular Sciences.

Pathological features in paediatric patients with TK2 deficiency. International Journal of Molecular Sciences.

Gul Cirkin | Molecular Medicine | Best Researcher Award

Published on by Molecular Biologist

Dr. Gul Cirkin | Molecular Medicine | Best Researcher Award 

Pediatric Gastroenterologist | Tepecik Training and Research Hospital, Izmir | Turkey 

Dr. Gül Çirkin is a highly accomplished Pediatric Gastroenterologist currently serving at Tepecik Training and Research Hospital in İzmir, Turkey. Over the course of her career, she has built a strong foundation in pediatrics and subspecialized in pediatric gastroenterology, with a focus on improving child health through clinical excellence, research, and academic contributions. Her educational path began with a Doctor of Medicine degree from Dicle University Faculty of Medicine, followed by a Pediatrics Residency at Çukurova University Faculty of Medicine. She later pursued a Pediatric Gastroenterology Fellowship at Dokuz Eylül University Faculty of Medicine, where she deepened her expertise in pediatric hepatology, endoscopy, and nutritional disorders. Professionally, she has served as a research assistant, pediatrician, and pediatric gastroenterologist in leading hospitals across Turkey, gaining extensive clinical and academic experience. Her research interests include celiac disease, pediatric liver diseases, childhood obesity, nutritional disorders, and pediatric endoscopy. She has published in respected journals and actively presented her work at international conferences, including the European Society for Paediatric Gastroenterology, Hepatology and Nutrition and the European Society for Clinical Nutrition and Metabolism. Her contributions to research and clinical care have earned her recognition as a promising leader in pediatric gastroenterology and hepatology.

Profile: Scopus

Featured Publications

Trends in Pediatrics. (2021). Evaluation of success rate of exogenous obesity management. Trends in Pediatrics.

Trends in Pediatrics. (2022). Study of liver effect in children with celiac disease. Trends in Pediatrics.

Endoscopy. (2023). Botryoid rhabdomyosarcoma or parasites: Transnasal choledoscopy as a diagnostic tool. Endoscopy.

Medicine (Baltimore). (2024). Evaluation of endoscopic retrograde cholangiopancreatography in Turkish children. Medicine (Baltimore).

Turkish Journal of Gastroenterology. (2024). Clinical and molecular analysis in patients with Peutz–Jeghers syndrome. Turkish Journal of Gastroenterology.

Turkish Journal of Pediatrics. (2024). Evaluation of functional gastrointestinal disorders in children with autism spectrum disorder. Turkish Journal of Pediatrics.

Konstantinos Papageorgiou | Molecular Diagnostics | Best Researcher Award

Published on by Molecular Biologist

Assist. Prof. Dr. Konstantinos Papageorgiou | Molecular Diagnostics | Best Researcher Award 

School of Veterinary Medicine | Aristotle University of Thessaloniki | Greece

Dr. Konstantinos Papageorgiou is a Greek veterinarian and microbiologist with expertise in veterinary public health, infectious diseases, molecular diagnostics, food safety, and zoonoses. He earned his Bachelor of Veterinary Medicine at Aristotle University of Thessaloniki (AUTH) and later completed a PhD in Veterinary Microbiology from the same institution. For over two decades, he served as a military veterinarian and microbiologist in the Hellenic Army, where he led hygiene inspections, managed microbiological laboratories, ensured food safety standards, and oversaw molecular diagnostic departments. His international training in molecular virology, bioinformatics, and next-generation sequencing, combined with advanced certifications in biorisk and project risk management, strengthened his scientific and leadership profile. He transitioned to academia and is now Assistant Professor at the Laboratory of Microbiology and Infectious Diseases, AUTH, where he focuses on teaching, research, and laboratory management. His research interests include zoonoses, molecular diagnostics, laboratory quality systems, and environmental surveillance, with a particular focus on integrating advanced molecular methods and sequencing technologies into pathogen detection and public health monitoring. His contributions include studies on zoonotic viruses such as Pseudorabies Virus in wildlife, while his academic output reflects 29 documents, 255 citations by 250 documents, and an h-index of 10, highlighting his impact in veterinary microbiology and public health. Through his interdisciplinary background, he bridges animal health, public health, and laboratory science to enhance infectious disease surveillance and control.

Profile: Scopus | ORCID | Google Scholar

Featured Publications

Detection of pseudorabies virus in hunting dogs in Greece: The role of wild boars in virus transmission. Pathogens. MDPI.

Pseudorabies virus prevalence in lung samples of hunted wild boars in Northwestern Greece. Pathogens. MDPI.

Phenotypic and molecular patterns of resistance among Campylobacter coli and Campylobacter jejuni isolates from pig farms. Animals. Aristotle University of Thessaloniki.

Maria Camprubi Robles | Molecular Biology | Best Researcher Award

Published on by Molecular Biologist

Dr. Maria Camprubi Robles | Molecular Biology | Best Researcher Award 

Research Scientist | Abbott Laboratories | Spain

Dr. Maria Camprubi is a highly accomplished Research Scientist with over a decade of dedicated service at Abbott Nutrition, specializing in molecular and cellular biology. With strong expertise in nutritional science, she has significantly contributed to the development of innovative products that address sarcopenia, chronic disease, and malnutrition across Europe, the Middle East, and Africa. She holds a Ph.D. in Molecular and Cellular Biology, where she built a strong foundation in cellular processes and metabolic regulation. Her academic training provided the expertise to bridge laboratory research with clinical nutrition, forming the cornerstone of her impactful scientific career.  Dr. Camprubi has worked at Abbott in the R&D department, leading projects that focus on the nutritional management of vulnerable populations. Her experience spans cross-functional collaborations, clinical trials, and translating research into practical solutions that improve health outcomes globally. Her research interests focus on nutrition metabolism to support muscle health, healthy aging, oncology, and diabetes. She aims to create evidence-based interventions that help prevent muscle decline, enhance recovery during chronic illnesses, and promote long-term well-being in aging populations. Dr. Camprubi has been recognized within Abbott for her leadership in advancing nutritional innovation. Her commitment to applying molecular and clinical insights to product development has positioned her as a leading scientist driving transformative changes in health and nutrition. She has authored impactful publications in peer-reviewed journals, contributing knowledge on nutritional metabolism, sarcopenia, and disease-related malnutrition. Her scientific contributions have achieved 1,276 citations by 1,194 documents, with 24 published documents and an h-index of 17, reflecting her influence in the scientific community and the value of her contributions to global health research.

Profile: Scopus

Featured Publications

A prospective, observational study of the effect of a high-calorie, high-protein oral nutritional supplement with HMB in an old and malnourished or at-risk-of-malnutrition population with hip fractures: A FracNut study. Nutrients, 16(8)

The vicious cycle of type 2 diabetes mellitus and skeletal muscle atrophy: Clinical, biochemical, and nutritional bases. Nutrients, 16(1), 172